Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary hypertension.

Vallerie V McLaughlin1, Stuart Rich

  • 1United Therapeutics. vmclaugh@umich.edu

Current Problems in Cardiology
|October 21, 2004
PubMed
Summary

Pulmonary hypertension involves elevated pulmonary artery pressure, leading to right ventricular dysfunction. Recent advancements offer new therapies for pulmonary arterial hypertension, improving outcomes for this serious condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sotatercept Safety and Efficacy in Intermediate- to Low-Risk Pulmonary Arterial Hypertension: A Pooled Analysis of PULSAR and STELLAR.

Chest·2026
Same author

Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension.

American journal of respiratory and critical care medicine·2026
Same author

Sotatercept and Prostacyclin De-Escalation in Stable Pulmonary Arterial Hypertension: A Single-Centre Case Series.

American journal of respiratory and critical care medicine·2026
Same author

From Clinical Success to Physiologic Understanding: Disentangling Sotatercept's Effects in PAH.

Journal of the American College of Cardiology·2026
Same author

Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension.

American journal of respiratory and critical care medicine·2026
Same author

Macitentan and phosphodiesterase-5 inhibitor alone or in combination in newly diagnosed pulmonary arterial hypertension: a pooled analysis.

JHLT open·2026

Area of Science:

  • Cardiology
  • Pulmonology
  • Medical Research

Background:

  • Pulmonary hypertension is characterized by elevated pulmonary artery pressure, potentially causing right ventricular dysfunction.
  • The causes of pulmonary hypertension are diverse, necessitating varied treatment approaches.
  • Significant progress in understanding pulmonary arterial hypertension mechanisms and therapies has occurred in the last decade.

Purpose of the Study:

  • To discuss the varied causes and treatments of pulmonary hypertension.
  • To highlight recent advancements in therapies for pulmonary arterial hypertension.
  • To provide an overview of different forms of pulmonary hypertension, including pulmonary venous hypertension, respiratory disease-related pulmonary hypertension, and thromboembolic pulmonary hypertension.

Main Methods:

  • Review of current medical literature on pulmonary hypertension.
  • Discussion of established and emerging treatment modalities.
  • Categorization of pulmonary hypertension based on underlying causes.

Main Results:

  • Pulmonary hypertension is a complex condition with multiple underlying causes.
  • New FDA-approved therapies like intravenous epoprostenol, subcutaneous treprostinil, and oral bosentan have emerged for pulmonary arterial hypertension.
  • Various forms of pulmonary hypertension require distinct management strategies.

Conclusions:

  • Pulmonary hypertension management is tailored to its specific etiology.
  • Therapeutic options for pulmonary arterial hypertension have expanded significantly, improving patient prognosis.
  • Further research into diverse pulmonary hypertension types is warranted.

Related Experiment Videos